Containment of carbapenemase-producing carbapenem resistant enterobacterales viaimplementation of the global action in healthcare network antimicrobial resistance module: the experience of Argentina and Chile, march 2022 – october 2024 Navegación de entradas In vitro activity of cefepime/zidebactam (FPZ) against Extended-spectrum b-lactamase(ESBL) producers and Carbapenem-resistant Enterobacterales (CRE) isolates In vitro activity of Mecillinam against multi-drug resistant Enterobacterales